Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitetm-partners.com
Twitter@thomasmcnerney
Phone203-978-2000
Employees
Founded2003

Funds

Offices

HQ
One Landmark Square
Suite 1920
Stamford, CT, 06901
USA
Minneapolis, USA
60 South 6th Street
Suite 3620
Minneapolis, MN, 55402
USA
La Jolla, USA
3366 N. Torrey Pines Court
Suite 220
La Jolla, CA, 92037
USA

People

Founder
Partner
Partner
Partner
Partner
Partner
Partner
CFO
Show All People

Tags

Thomas, McNerney & Partners

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in life science and medical technology companies.

The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors as well as in other areas utilizing medical technology innovation. Companies developing therapeutic products for life threatening or costly, chronic conditions are of particular interest.

Thomas, McNerney & Partners invests in companies at all stages of their development. In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization. The partnership also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies as well as recapitalizations.

Recent Milestones

Investments

Company Date Round Size Participants
Auspex Pharmaceuticals 1/2014Series E$20M5
AxioMed Spine 1/2013Series D$3.6M5
Auspex Pharmaceuticals 11/2012Series D$25M4
Cebix 10/2012Series C$30.9M3
Torax Medical 9/2012Series D$30M5
Tioga Pharmaceuticals 4/2012Series B$10M2
SG Biofuels 1/2012Series B$17M4
InnoPharma 12/2011Series A$15M1
CAS Medical Systems 6/2011Venture Round$15M1
AxioMed Spine 10/2010Series D$15M7
Auspex Pharmaceuticals 10/2010Series C$12M3
Celator Pharmaceuticals 9/2010Series D$20M7
Cebix 9/2010Venture Round$16M3
Zogenix 7/2010Venture Round$15M5
NeuroTherapeutics Pharma 5/2010Series B$43M4
Altair Therapeutics 2/2010Series B$17M4
Intuity Medical 1/2010Series D$64M6
Virdante Pharmaceuticals 11/2009Series A$30M6
Quinnova Pharmaceuticals 11/2009Series B$17.4M3
Galil Medical 12/2006Venture Round$52M3
Solstice Neurosciences 11/2006Series B$85M5
Zogenix 8/2006Series A$60M5
Solstice Neurosciences 7/2005Venture Round$8M4
Torax Medical 6/2005Series B$10M3

Videos

Sources

  1. Auspex Raises $35 Million and Appoints Industry Veteran Gerald Proehl to its Board of Directors (auspexpharma.com) [edit]
  2. AxioMed Spine Raises $3.6M in Funding (finsmes.com) [edit]
  3. Auspex Pharmaceuticals Closes $25 Million Series D Financing (in.finance.yahoo.com) [edit]
  4. Cebix Incorporated Inks $30.9m Series C and Appoints President and CEO (pehub.com) [edit]
  5. Torax Medical Completes $30M Series D Financing (finsmes.com) [edit]
  6. Tioga Pharmaceuticals, Inc. Raises $10 Million to Advance Phase 3 Clinical Development of Asimadoline in Irritable Bowel Syndrome (tiogapharma.com) [edit]
  7. SG Biofuels Raises $17M From Thomas McNerney, Finistere, Others (businessreel.com) [edit]
  8. InnoPharma Closes $15M Series A Financing (finsmes.com) [edit]
  9. CAS Medical Systems Raises $15 Million in Private Placement (devicespace.com) [edit]
  10. **OnBioVC Post 1,000** AxioMed Spine Corp.: Series D $15M (onbiovc.com) [edit]
  11. Auspex Pharmaceuticals, Inc.: $12M Series C (onbiovc.com) [edit]
  12. CELATOR® PHARMACEUTICALS RAISES $20 MILLION IN SERIES D FINANCING (celatorpharma.com) [edit]
  13. Cebix Raises $16M From Investors (xconomy.com) [edit]
  14. Zogenix Secures $35 Million Debt Facility And Raises $15 Million Investment Capital (zogenix.com) [edit]
  15. Big Pharma firms back $43M round for NeuroTherapeutics (fiercebiotech.com) [edit]
  16. Altair Therapeutics, Inc.: Series B $17M (onbiovc.com) [edit]
  17. Intuity Medical Secures $64M in Series D Financing Round (finsmes.com) [edit]
  18. Virdante Pharmaceuticals, Inc.: Series A $30M (onbiovc.com) [edit]
  19. Quinnova Pharmaceuticals, Inc.: Series B $17.4M (onbiovc.com) [edit]
  20. company press release (galil-medical.com) [edit]
  21. Solstice Neurosciences Raises $85 Million in Private Financing (solsticeneuro.com) [edit]
  22. Zogenix, Inc. Raises $60 Million In Series A Venture Financing; Names Board of Directors (zogenix.com) [edit]
  23. EDGAR [edit]
  24. Torax Medical lands $10M in financing (bizjournals.com) [edit]
Edit This Page
Last Edited 3/13/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy